OVERVIEW

We invite you to join us at our 2023 Community Cases program hosted in Tampa, Florida. This program will consist of educational activities designed to meet the educational needs of medical oncologists, pharmacists, advanced practitioners, and nurses involved in the treatment of breast, GI, lung, and hematological cancers. The agenda is comprised of short data presentations followed by community-friendly, concise case-based integration. These meetings will be hybrid (in-person and virtual). 

LEARNING OBJECTIVES

• Employ an understanding of personalized medicine to individualize the use of available drugs for breast, GI, GU, lung, and hematological cancers. 
• Communicate the efficacy and safety of the drugs discussed in the case studies and other emerging treatments for breast, GI, GU, lung, and hematological cancers. 
• Understand the emerging and standard diagnostic tests used to assist in planning therapy for breast, GI, GU, lung, and hematological cancers. 
• Formulate management strategies, considering the contributory roles of local and systemic therapy. 
• Recall the design of ongoing clinical trials evaluating novel investigational agents and counsel appropriately selected patients about availability and participation. 

ACCREDITATION

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Total Health Conferencing.  Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME).

Amedco LLC designates this live activity for a maximum of TBD AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

For more information please visit the official event page.